Symbols / SBFM $1.00 +3.22% Sunshine Biopharma, Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • United States • NCM
SBFM Chart
About

Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Drug Manufacturers - Spe Market Cap 4.91M
Enterprise Value -3.55M Income -5.98M Sales 36.31M
Book/sh 4.69 Cash/sh 1.86 Dividend Yield —
Payout 0.00% Employees 50 IPO —
P/E 0.20 Forward P/E 0.01 PEG —
P/S 0.14 P/B 0.21 P/C —
EV/EBITDA 0.85 EV/Sales -0.10 Quick Ratio 1.95
Current Ratio 4.17 Debt/Eq 3.53 LT Debt/Eq —
EPS (ttm) -1.44 EPS next Y 199.80 EPS Growth —
Revenue Growth -10.60% Earnings 2026-04-03 11:00 ROA -9.23%
ROE -25.68% ROIC — Gross Margin 33.76%
Oper. Margin -19.33% Profit Margin -16.46% Shs Outstand 4.91M
Shs Float 4.90M Short Float 3.39% Short Ratio 4.38
Short Interest — 52W High 2.43 52W Low 0.95
Beta 1.60 Avg Volume 37.06K Volume 28.40K
Target Price $5.60 Recom Strong_buy Prev Close $0.97
Price $1.00 Change 3.22%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$5.60
Mean price target
2. Current target
$1.00
Latest analyst target
3. DCF / Fair value
$-17.00
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.00
Low
$5.60
High
$5.60
Mean
$5.60

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-10-08 reit Aegis Capital Buy → Buy $7
2024-12-05 reit Aegis Capital Buy → Buy $15
2023-08-07 init Aegis Capital — → Buy $3
News
RSS: Latest SBFM news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
36.31
+4.11%
34.87
+44.75%
24.09
+454.42%
4.35
Operating Revenue
36.31
+4.11%
34.87
+44.75%
24.09
+454.42%
4.35
Cost Of Revenue
24.05
-0.64%
24.20
+53.64%
15.75
+494.69%
2.65
Reconciled Cost Of Revenue
24.05
-0.64%
24.20
+53.64%
15.75
+494.69%
2.65
Gross Profit
12.26
+14.86%
10.67
+27.95%
8.34
+391.53%
1.70
Operating Expense
16.73
+1.53%
16.48
+25.58%
13.12
+26.55%
10.37
Research And Development
0.60
-35.29%
0.93
-49.68%
1.86
+128.59%
0.81
Selling General And Administration
15.33
+2.62%
14.94
+37.93%
10.83
+14.26%
9.48
Selling And Marketing Expense
1.14
+21.66%
0.94
+28.06%
0.73
+27.01%
0.58
General And Administrative Expense
14.18
+1.34%
14.00
+38.65%
10.10
+13.43%
8.90
Salaries And Wages
7.67
-5.58%
8.12
+32.81%
6.11
-3.81%
6.35
Other Gand A
6.52
+10.90%
5.88
+47.61%
3.98
+56.47%
2.55
Total Expenses
40.78
+0.24%
40.69
+40.89%
28.88
+121.80%
13.02
Operating Income
-4.48
+22.94%
-5.81
-21.46%
-4.79
+44.83%
-8.67
Total Operating Income As Reported
-6.23
-7.14%
-5.81
-21.46%
-4.79
+82.28%
-27.00
EBITDA
-5.62
-9.44%
-5.14
-34.31%
-3.82
+85.54%
-26.45
Normalized EBITDA
-3.87
+24.09%
-5.09
-33.17%
-3.82
+52.96%
-8.13
Reconciled Depreciation
0.33
+48.56%
0.22
+49.87%
0.15
+492.72%
0.03
EBIT
-5.95
-11.07%
-5.36
-34.90%
-3.97
+84.99%
-26.47
Total Unusual Items
-1.76
-3883.17%
-0.04
-17892.65%
-0.00
+100.00%
-18.32
Total Unusual Items Excluding Goodwill
-1.76
-3883.17%
-0.04
-17892.65%
-0.00
+100.00%
-18.32
Special Income Charges
-1.76
0.00
0.00
+100.00%
-18.32
Other Special Charges
—
—
—
-0.01
Impairment Of Capital Assets
1.75
0.00
0.00
-100.00%
18.33
Net Income
-5.98
-16.39%
-5.13
-13.94%
-4.51
+83.15%
-26.74
Pretax Income
-5.95
-10.89%
-5.37
-30.60%
-4.11
+84.49%
-26.51
Net Non Operating Interest Income Expense
0.28
-42.35%
0.49
-27.78%
0.67
+40.78%
0.48
Interest Expense Non Operating
0.00
-100.00%
0.01
-93.61%
0.14
+248.39%
0.04
Net Interest Income
0.28
-42.35%
0.49
-27.78%
0.67
+40.78%
0.48
Interest Expense
0.00
-100.00%
0.01
-93.61%
0.14
+248.39%
0.04
Interest Income Non Operating
0.28
-43.37%
0.50
-38.91%
0.81
+56.56%
0.52
Interest Income
0.28
-43.37%
0.50
-38.91%
0.81
+56.56%
0.52
Other Income Expense
-1.76
-3883.17%
-0.04
-17892.65%
-0.00
+100.00%
-18.32
Gain On Sale Of Security
0.00
+105.99%
-0.04
-17892.65%
-0.00
+48.53%
-0.00
Tax Provision
0.02
+109.20%
-0.23
-159.43%
0.40
+69.38%
0.23
Tax Rate For Calcs
0.00
+380.07%
0.00
-79.17%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-0.37
-19022.04%
-0.00
-3647.92%
-0.00
+100.00%
-3.85
Net Income Including Noncontrolling Interests
-5.98
-16.39%
-5.13
-13.94%
-4.51
+83.15%
-26.74
Net Income From Continuing Operation Net Minority Interest
-5.98
-16.39%
-5.13
-13.94%
-4.51
+83.15%
-26.74
Net Income From Continuing And Discontinued Operation
-5.98
-16.39%
-5.13
-13.94%
-4.51
+83.15%
-26.74
Net Income Continuous Operations
-5.98
-16.39%
-5.13
-13.94%
-4.51
+83.15%
-26.74
Normalized Income
-4.59
+9.89%
-5.09
-13.01%
-4.51
+63.29%
-12.27
Net Income Common Stockholders
-5.98
-16.39%
-5.13
-13.94%
-4.51
+83.15%
-26.74
Diluted EPS
—
-7.32
+97.92%
-351.36
+90.02%
-3,520.00
Basic EPS
—
-7.32
+97.92%
-351.36
+90.02%
-3,520.00
Basic Average Shares
—
0.70
+5371.73%
0.01
+68.97%
0.01
Diluted Average Shares
—
0.70
+5371.73%
0.01
+68.97%
0.01
Diluted NI Availto Com Stockholders
-5.98
-16.39%
-5.13
-13.94%
-4.51
+83.15%
-26.74
Depreciation Amortization Depletion Income Statement
0.33
+48.56%
0.22
+49.87%
0.15
+492.72%
0.03
Depreciation And Amortization In Income Statement
0.33
+48.56%
0.22
+49.87%
0.15
+492.72%
0.03
Depreciation Income Statement
—
—
—
—
Gain On Sale Of PPE
-0.01
0.00
—
—
Other Taxes
0.47
+21.27%
0.39
+33.57%
0.29
+424.57%
0.06
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
30.08
-1.57%
30.56
+11.75%
27.35
-6.49%
29.24
Current Assets
26.85
+3.42%
25.97
+4.32%
24.89
-8.87%
27.31
Cash Cash Equivalents And Short Term Investments
9.12
-5.81%
9.69
-40.55%
16.29
-25.35%
21.83
Cash And Cash Equivalents
9.12
-5.81%
9.69
-40.55%
16.29
-25.35%
21.83
Cash Financial
9.12
-5.81%
9.69
-40.55%
16.29
-25.35%
21.83
Receivables
3.46
-10.56%
3.87
+51.56%
2.55
+33.48%
1.91
Accounts Receivable
3.46
-10.56%
3.87
+51.56%
2.55
+33.48%
1.91
Inventory
13.47
+19.45%
11.28
+96.66%
5.73
+74.31%
3.29
Finished Goods
13.47
+19.45%
11.28
+96.66%
5.73
—
Prepaid Assets
0.80
-29.55%
1.13
+264.88%
0.31
+9.44%
0.28
Total Non Current Assets
3.21
-30.22%
4.59
+86.98%
2.46
+27.20%
1.93
Net PPE
1.32
-11.19%
1.48
+46.36%
1.01
-12.30%
1.15
Gross PPE
1.83
+0.58%
1.82
+51.22%
1.20
-2.89%
1.24
Accumulated Depreciation
-0.51
-52.40%
-0.34
-77.13%
-0.19
-126.71%
-0.08
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
0.78
-16.79%
0.94
+44.72%
0.65
—
Machinery Furniture Equipment
0.62
+36.00%
0.46
+24.86%
0.37
+16.11%
0.32
Other Properties
0.34
-0.42%
0.34
+96.02%
0.17
-81.38%
0.92
Leases
0.09
+4.98%
0.09
+399.92%
0.02
0.00
Goodwill And Other Intangible Assets
1.89
-37.43%
3.02
+109.08%
1.44
+85.91%
0.78
Non Current Deferred Assets
0.00
-100.00%
0.09
0.00
—
Non Current Deferred Taxes Assets
0.00
-100.00%
0.09
0.00
—
Total Liabilities Net Minority Interest
7.04
-0.27%
7.06
+14.99%
6.14
-19.39%
7.62
Current Liabilities
6.44
+2.04%
6.31
+13.74%
5.55
-19.90%
6.93
Payables And Accrued Expenses
6.23
+1.98%
6.11
+12.41%
5.43
-20.19%
6.81
Payables
6.23
+1.98%
6.11
+12.41%
5.43
-20.19%
6.81
Accounts Payable
5.66
+2.19%
5.54
+114.39%
2.59
-7.75%
2.80
Other Payable
0.30
+0.00%
0.30
-88.39%
2.55
-29.85%
3.63
Current Accrued Expenses
—
—
—
0.00
Total Tax Payable
0.27
+0.00%
0.27
-10.54%
0.30
-19.65%
0.37
Income Tax Payable
0.27
+0.00%
0.27
-10.54%
0.30
-19.65%
0.37
Current Debt And Capital Lease Obligation
0.22
+3.79%
0.21
+75.07%
0.12
-3.54%
0.12
Current Debt
—
—
—
3.63
Other Current Borrowings
—
—
—
3.63
Current Capital Lease Obligation
0.22
+3.79%
0.21
+75.07%
0.12
-3.54%
0.12
Other Current Liabilities
—
—
—
0.12
Total Non Current Liabilities Net Minority Interest
0.60
-19.86%
0.74
+26.70%
0.59
-14.23%
0.69
Long Term Debt And Capital Lease Obligation
0.60
-19.86%
0.74
+38.16%
0.54
-16.07%
0.64
Long Term Debt
—
—
—
—
Long Term Capital Lease Obligation
0.60
-19.86%
0.74
+38.16%
0.54
-16.07%
0.64
Non Current Deferred Liabilities
—
0.00
-100.00%
0.05
+13.24%
0.04
Non Current Deferred Taxes Liabilities
—
0.00
-100.00%
0.05
+13.24%
0.04
Stockholders Equity
23.04
-1.97%
23.50
+10.81%
21.21
-1.94%
21.63
Common Stock Equity
23.03
-1.97%
23.49
+10.76%
21.21
-1.94%
21.63
Capital Stock
0.02
+14.92%
0.02
+1436.49%
0.00
-95.70%
0.02
Common Stock
0.00
+90.12%
0.00
+18328.57%
0.00
-99.94%
0.02
Preferred Stock
0.01
+0.00%
0.01
+1200.00%
0.00
+0.00%
0.00
Share Issued
4.91
+90.15%
2.58
+18313.49%
0.01
+24.09%
0.01
Ordinary Shares Number
4.91
+90.15%
2.58
+18313.49%
0.01
+24.09%
0.01
Additional Paid In Capital
98.10
+5.08%
93.35
+10.59%
84.42
+4.42%
80.84
Retained Earnings
-75.02
-8.65%
-69.04
-8.03%
-63.91
-7.59%
-59.40
Gains Losses Not Affecting Retained Earnings
-0.07
+92.13%
-0.83
-219.23%
0.70
+330.10%
0.16
Other Equity Adjustments
-0.07
+92.13%
-0.83
-219.23%
0.70
+330.10%
0.16
Total Equity Gross Minority Interest
23.04
-1.97%
23.50
+10.81%
21.21
-1.94%
21.63
Total Capitalization
23.04
-1.97%
23.50
+10.81%
21.21
-1.94%
21.63
Working Capital
20.41
+3.86%
19.65
+1.62%
19.34
-5.12%
20.38
Invested Capital
23.03
-1.97%
23.49
+10.76%
21.21
-1.94%
21.63
Total Debt
0.81
-14.70%
0.95
+44.82%
0.66
-14.05%
0.77
Capital Lease Obligations
0.81
-14.70%
0.95
+44.82%
0.66
-14.05%
0.77
Net Tangible Assets
21.15
+3.26%
20.48
+3.63%
19.76
-5.22%
20.85
Tangible Book Value
21.14
+3.26%
20.47
+3.57%
19.76
-5.22%
20.85
Current Notes Payable
—
—
—
—
Interest Payable
—
—
—
0.00
Preferred Stock Equity
0.01
+0.00%
0.01
+1200.00%
0.00
+0.00%
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-5.33
+57.44%
-12.52
-42.73%
-8.78
-67.20%
-5.25
Cash Flow From Continuing Operating Activities
-5.33
+57.44%
-12.52
-42.73%
-8.78
-67.20%
-5.25
Net Income From Continuing Operations
-5.98
-16.39%
-5.13
-13.94%
-4.51
+83.15%
-26.74
Depreciation Amortization Depletion
0.33
+48.56%
0.22
+49.87%
0.15
+492.72%
0.03
Depreciation
—
0.15
+32.35%
0.11
—
Amortization Cash Flow
—
0.08
+100.30%
0.04
—
Depreciation And Amortization
0.33
+48.56%
0.22
+49.87%
0.15
+492.72%
0.03
Amortization Of Intangibles
—
0.08
+100.30%
0.04
—
Other Non Cash Items
—
-2.24
—
-0.01
Asset Impairment Charge
1.75
0.00
0.00
-100.00%
18.33
Deferred Tax
—
0.00
0.00
—
Deferred Income Tax
—
0.00
0.00
—
Operating Gains Losses
0.01
—
—
0.00
Net Foreign Currency Exchange Gain Loss
—
—
0.00
-100.00%
0.00
Gain Loss On Sale Of PPE
0.01
0.00
—
—
Change In Working Capital
-1.45
+73.09%
-5.37
-21.64%
-4.42
-240.06%
3.15
Change In Receivables
-0.12
+95.03%
-2.34
-293.54%
-0.59
-13.28%
-0.52
Changes In Account Receivables
-0.12
+95.03%
-2.34
-293.54%
-0.59
-13.28%
-0.52
Change In Inventory
-1.64
+72.74%
-6.01
-153.93%
-2.37
-5603.45%
0.04
Change In Prepaid Assets
0.48
+332.08%
-0.21
-879.84%
-0.02
-125.52%
0.08
Change In Payables And Accrued Expense
-0.19
-105.99%
3.17
+320.66%
-1.44
-140.45%
3.55
Change In Accrued Expense
—
—
0.00
+100.00%
-0.05
Change In Payable
-0.19
-105.99%
3.17
+320.66%
-1.44
-139.91%
3.60
Change In Account Payable
-0.19
-104.77%
3.98
+392.04%
-1.36
-140.61%
3.36
Change In Other Current Assets
0.20
+159.68%
-0.34
—
—
Change In Other Current Liabilities
-0.19
-153.90%
0.35
—
—
Investing Cash Flow
-0.84
+57.75%
-1.98
-201.66%
-0.66
+95.51%
-14.62
Cash Flow From Continuing Investing Activities
-0.84
+57.75%
-1.98
-201.66%
-0.66
+95.51%
-14.62
Cash From Discontinued Investing Activities
—
—
—
—
Net PPE Purchase And Sale
-0.17
+89.47%
-1.66
-3434.25%
0.05
+130.94%
-0.16
Purchase Of PPE
-0.17
+89.47%
-1.66
-1914.63%
-0.08
+57.60%
-0.19
Sale Of PPE
—
—
0.13
+295.31%
0.03
Capital Expenditure
-0.84
+57.75%
-1.98
-151.15%
-0.79
-158.40%
-0.30
Net Business Purchase And Sale
—
—
0.00
+100.00%
-14.35
Purchase Of Business
—
—
0.00
+100.00%
-14.35
Net Intangibles Purchase And Sale
-0.66
-105.37%
-0.32
+54.34%
-0.71
-535.81%
-0.11
Purchase Of Intangibles
-0.66
-105.37%
-0.32
+54.34%
-0.71
-535.81%
-0.11
Financing Cash Flow
4.75
-46.90%
8.94
+161.02%
3.43
-91.32%
39.47
Cash Flow From Continuing Financing Activities
4.75
-46.90%
8.94
+161.02%
3.43
-91.32%
39.47
Net Issuance Payments Of Debt
—
0.35
+376.16%
-0.13
+93.48%
-1.93
Issuance Of Debt
—
—
—
0.00
Repayment Of Debt
—
—
0.00
+100.00%
-1.90
Long Term Debt Issuance
—
—
—
0.00
Long Term Debt Payments
—
—
0.00
+100.00%
-1.90
Net Long Term Debt Issuance
—
0.35
+376.16%
-0.13
+93.48%
-1.93
Net Common Stock Issuance
1.83
-66.03%
5.38
+51.71%
3.55
-88.28%
30.27
Common Stock Payments
0.00
+100.00%
-3.14
-480.19%
-0.54
-446.61%
-0.10
Repurchase Of Capital Stock
0.00
+100.00%
-3.14
-480.19%
-0.54
-446.61%
-0.10
Proceeds From Stock Option Exercised
2.92
-17.96%
3.56
+101522.27%
0.00
-99.97%
13.19
Net Other Financing Charges
—
—
—
-2.06
Changes In Cash
-1.42
+74.49%
-5.56
+7.38%
-6.01
-130.65%
19.60
Effect Of Exchange Rate Changes
0.86
+182.02%
-1.04
-321.23%
0.47
+156.42%
0.18
Beginning Cash Position
9.69
-40.55%
16.29
-25.35%
21.83
+967.22%
2.05
End Cash Position
9.12
-5.81%
9.69
-40.55%
16.29
-25.35%
21.83
Free Cash Flow
-6.17
+57.48%
-14.50
-51.67%
-9.56
-72.21%
-5.55
Interest Paid Supplemental Data
0.00
-100.00%
0.01
0.00
-100.00%
0.05
Income Tax Paid Supplemental Data
0.00
-100.00%
0.58
0.00
0.00
Change In Income Tax Payable
0.00
+100.00%
-0.81
-1008.69%
-0.07
-130.23%
0.24
Change In Interest Payable
—
—
0.00
+100.00%
-0.05
Change In Tax Payable
0.00
+100.00%
-0.81
-1008.69%
-0.07
-130.23%
0.24
Common Stock Issuance
1.83
-78.54%
8.52
+108.41%
4.09
-86.53%
30.37
Issuance Of Capital Stock
1.83
-78.54%
8.52
+108.41%
4.09
-86.53%
30.37
Net Preferred Stock Issuance
—
—
—
-0.10
Preferred Stock Payments
—
—
—
-0.10
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category